EYEN: Eyenovia, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.09
Enterprise Value ($M) 13.47
Book Value ($M) 3.72
Book Value / Share 0.04
Price / Book 2.44
NCAV ($M) -7.39
NCAV / Share -0.09
Price / NCAV -1.23

Profitability (mra)
Return on Invested Capital (ROIC) -2.26
Return on Assets (ROA) -1.09
Return on Equity (ROE) -2.40

Liquidity (mrq)
Quick Ratio 0.55
Current Ratio 0.74

Balance Sheet (mrq) ($M)
Current Assets 11.69
Assets 22.80
Liabilities 19.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 9.95 96.44
07-18 13D/A Ianchulev Tsontcho 3.20 -7.93

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 6,723,676 19,496,021 34.49
2024-11-21 5,212,884 13,245,863 39.35
2024-11-20 6,902,281 24,945,287 27.67
2024-11-19 3,625,335 12,059,211 30.06

(click for more detail)

Similar Companies
ERNA – Eterna Therapeutics Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc. FBIO – Fortress Biotech, Inc.
FBRX – Forte Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.